Omada Health, Inc. (OMDA)

Omada Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	232.34	169.8	122.78	89.19
Revenue Growth (YoY)	89.23%	38.29%	37.67%	-
Cost of Revenue	82.93	66.92	52.81	46.39
Gross Profit	149.41	102.88	69.97	42.79
Selling, General & Admin	133.44	110.61	102.23	88.97
Research & Development	38.32	35.92	33.74	26.17
Operating Expenses	171.76	146.53	135.97	115.14
Operating Income	-22.35	-43.65	-66	-72.35
Interest Expense	-3.62	-4.51	-4.71	-4.2
Interest & Investment Income	3.59	0.81	5.78	2.2
Other Non Operating Income (Expenses)	-1.7	0.22	-1.05	1.83
EBT Excluding Unusual Items	-24.08	-47.14	-65.98	-72.52
Other Unusual Items	-2.11	-	-1.54	-
Pretax Income	-26.19	-47.14	-67.51	-72.52
Net Income	-26.19	-47.14	-67.51	-72.52
Net Income to Common	-26.19	-47.14	-67.51	-72.52
Shares Outstanding (Basic)	24	8	7	7
Shares Outstanding (Diluted)	24	8	7	7
Shares Change (YoY)	239.22%	8.89%	4.59%	-
EPS (Basic)	-1.09	-6.10	-9.52	-10.70
EPS (Diluted)	-1.09	-6.10	-9.52	-10.70
Free Cash Flow	-10.92	-34.78	-50.15	-69.7
Free Cash Flow Per Share	-0.45	-4.50	-7.07	-10.28
Gross Margin	64.31%	60.59%	56.99%	47.98%
Operating Margin	-9.62%	-25.71%	-53.75%	-81.12%
Profit Margin	-11.27%	-27.76%	-54.98%	-81.31%
Free Cash Flow Margin	-4.70%	-20.48%	-40.85%	-78.15%
EBITDA	-17.03	-38.85	-61.55	-68.02
EBITDA Margin	-7.33%	-22.88%	-50.13%	-76.27%
D&A For EBITDA	5.32	4.8	4.45	4.33
EBIT	-22.35	-43.65	-66	-72.35
EBIT Margin	-9.62%	-25.71%	-53.75%	-81.12%
Revenue as Reported	232.34	169.8	122.78	89.19
Advertising Expenses	-	0.5	0.8	0.7

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q